SNY
Price
$54.47
Change
+$0.34 (+0.63%)
Updated
Feb 21, 04:59 PM (EDT)
Capitalization
122.61B
61 days until earnings call
SNYNF
Price
$108.11
Change
+$2.36 (+2.23%)
Updated
Feb 18 closing price
Capitalization
134.16B
Ad is loading...

SNY vs SNYNF

Header iconSNY vs SNYNF Comparison
Open Charts SNY vs SNYNFBanner chart's image
Sanofi ADS
Price$54.47
Change+$0.34 (+0.63%)
Volume$23.12K
Capitalization122.61B
Sanofi
Price$108.11
Change+$2.36 (+2.23%)
Volume$356
Capitalization134.16B
SNY vs SNYNF Comparison Chart
Loading...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNY vs. SNYNF commentary
Feb 22, 2025

To understand the difference between Sanofi - ADR (SNY) vs. Sanofi (SNYNF) it is enough to know the definitions of ADR

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (SNY: $54.13 vs. SNYNF: $108.11)
Brand notoriety: SNY and SNYNF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: SNY: 46% vs. SNYNF: 31%
Market capitalization -- SNY: $122.61B vs. SNYNF: $134.16B
SNY [@Pharmaceuticals: Major] is valued at $122.61B. SNYNF’s [@Pharmaceuticals: Major] market capitalization is $134.16B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNY’s FA Score shows that 1 FA rating(s) are green whileSNYNF’s FA Score has 1 green FA rating(s).

  • SNY’s FA Score: 1 green, 4 red.
  • SNYNF’s FA Score: 1 green, 4 red.
According to our system of comparison, SNY is a better buy in the long-term than SNYNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNY’s TA Score shows that 5 TA indicator(s) are bullish.

  • SNY’s TA Score: 5 bullish, 5 bearish.

Price Growth

SNY (@Pharmaceuticals: Major) experienced а +0.26% price change this week, while SNYNF (@Pharmaceuticals: Major) price change was -2.04% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.30%. For the same industry, the average monthly price growth was +2.42%, and the average quarterly price growth was -9.73%.

Reported Earning Dates

SNY is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.30% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNYNF($134B) has a higher market cap than SNY($123B). SNY has higher P/E ratio than SNYNF: SNY (20.80) vs SNYNF (14.04). SNYNF YTD gains are higher at: 13.680 vs. SNY (12.233). SNYNF has higher annual earnings (EBITDA): 13.8B vs. SNY (12.6B). SNY has more cash in the bank: 8.98B vs. SNYNF (7.99B). SNY has less debt than SNYNF: SNY (18.4B) vs SNYNF (21B). SNY (46.4B) and SNYNF (46.1B) have equivalent revenues.
SNYSNYNFSNY / SNYNF
Capitalization123B134B92%
EBITDA12.6B13.8B91%
Gain YTD12.23313.68089%
P/E Ratio20.8014.04148%
Revenue46.4B46.1B101%
Total Cash8.98B7.99B112%
Total Debt18.4B21B88%
FUNDAMENTALS RATINGS
SNY vs SNYNF: Fundamental Ratings
SNY
SNYNF
OUTLOOK RATING
1..100
1935
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
3975
SMR RATING
1..100
8181
PRICE GROWTH RATING
1..100
4846
P/E GROWTH RATING
1..100
3834
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNY's Valuation (12) in the Pharmaceuticals Major industry is in the same range as SNYNF (12) in the null industry. This means that SNY’s stock grew similarly to SNYNF’s over the last 12 months.

SNY's Profit vs Risk Rating (39) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNYNF (75) in the null industry. This means that SNY’s stock grew somewhat faster than SNYNF’s over the last 12 months.

SNY's SMR Rating (81) in the Pharmaceuticals Major industry is in the same range as SNYNF (81) in the null industry. This means that SNY’s stock grew similarly to SNYNF’s over the last 12 months.

SNYNF's Price Growth Rating (46) in the null industry is in the same range as SNY (48) in the Pharmaceuticals Major industry. This means that SNYNF’s stock grew similarly to SNY’s over the last 12 months.

SNYNF's P/E Growth Rating (34) in the null industry is in the same range as SNY (38) in the Pharmaceuticals Major industry. This means that SNYNF’s stock grew similarly to SNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SNY
RSI
ODDS (%)
Bearish Trend 3 days ago
30%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
45%
Momentum
ODDS (%)
Bullish Trend 3 days ago
59%
MACD
ODDS (%)
Bearish Trend 3 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
48%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
52%
Advances
ODDS (%)
Bullish Trend 11 days ago
54%
Declines
ODDS (%)
Bearish Trend 4 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
40%
Aroon
ODDS (%)
Bullish Trend 3 days ago
60%
View a ticker or compare two or three
Ad is loading...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EMCR30.740.28
+0.94%
Xtrackers EM CarbReduc&ClimtImprvs ETF
GHYB45.050.08
+0.18%
Goldman Sachs Access Hi Yld Corp Bd ETF
CGMS27.560.04
+0.15%
Capital Group U.S. Multi-Sector Inc ETF
FLDZ28.67N/A
N/A
RiverNorth Patriot ETF
QMAR30.86-0.01
-0.02%
FT Vest Nasdaq-100 Buffer ETF – Mar

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with SNYNF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then SNYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
+0.99%
SNYNF - SNY
61%
Loosely correlated
N/A
AZN - SNY
38%
Loosely correlated
+1.02%
NVS - SNY
38%
Loosely correlated
+0.37%
GSK - SNY
36%
Loosely correlated
+1.15%
JNJ - SNY
36%
Loosely correlated
+1.13%
More

SNYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNYNF has been loosely correlated with SNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SNYNF jumps, then SNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYNF
1D Price
Change %
SNYNF100%
N/A
SNY - SNYNF
37%
Loosely correlated
+0.99%
NVSEF - SNYNF
24%
Poorly correlated
-0.70%
AZN - SNYNF
23%
Poorly correlated
+1.02%
JNJ - SNYNF
22%
Poorly correlated
+1.13%
NVS - SNYNF
21%
Poorly correlated
+0.37%
More